NHS National Framework for Emtricitabine/Rilpivirine/Tenofovir Alafenamide 200 mg/25 mg/25 mg Odefsey or eqv.
Estimated value
£6.2m
Awarded value
—
Suppliers
0
Lots
1
Published
23 Apr 2026
This is a preliminary market engagement notice
Map the supplier landscape and document your shortlist before opening the tender. The market simulation produces a defensible audit record you can attach to your procurement file.
Description
Project title: NHS National Framework for Emtricitabine/Rilpivirine/Tenofovir Alafenamide 200 mg/25 mg/25 mg Odefsey or eqv. Offer reference number: CM/TNS/26/5753 Suppliers who are planning to introduce the molecule(s) detailed in the framework title, or who have any questions regarding a potential upcoming procurement exercise, are invited to contact the MPSC New Market Developments Team. Please email barbara.sly@nhs.net, marie.graney1@nhs.net, and katie.noonan@nhs.net
Scope
- Reference
- CM/TNS/26/5753
- Total value
- £6,200,000 excluding VAT£7,440,000 including VATAbove the relevant threshold
- Commercial tool
- Standalone contract
- Contract dates
- 30 Jun 2027 to 30 Jun 2028Possible extension to 30 Jun 2030
- Main category
- goods
- CPV classifications
- 33600000
- Contract locations
- North East England, United KingdomNorth West England, United KingdomEast Midlands, United KingdomWest Midlands, United KingdomEast of England, United KingdomSouth East England, United KingdomSouth West England, United Kingdom
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Procedure
- Open procedure